The third annual CARO-Elekta Research Fellowship awarded to
Dr. David Palma to further conduct research around Stereotactic
Radiotherapy for Lung Cancer
OTTAWA, Sept. 4 /CNW/ - The Canadian Association of Radiation Oncology
(CARO), along with international medical-technology group Elekta, are pleased
to award the 2009 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr.
David Palma. The $75,000 fellowship, provided by Elekta, will enable Dr. Palma
to conduct research with the Uro-Oncology Unit at the VU Medical Centre,
Amsterdam Radiation Oncology with Dr. Suresh Senan. His research will revolve
around Stereotactic Radiotherapy for Lung Cancer.
"In creating this fellowship, CARO and Elekta have provided an
outstanding opportunity for new radiation oncology graduates who wish to
pursue further research training.", said David, "This fellowship will allow me
to gain research experience from two different institutions abroad. Dr.
Senan's group at the Vrije University Medical Centre in Amsterdam has a strong
lung cancer radiotherapy program, focused on clinical trials and the
evaluation and implementation of new radiotherapy delivery technology. This
training will fit well with the academic program in Boston, hopefully
providing a strong foundation for a future research career."
This is the third year that the CARO-Elekta Research Fellowship Program
has been awarded. The fellowship will provide research and salary support to
Dr. Palma for a period of one year. His research is endorsed by both CARO and
Elekta as being directly relevant to the current and future practice of
radiation oncology, both in Canada and abroad.
"We are thrilled that CARO has been able to continue offering this
fellowship in conjunction with Elekta for a third year." said Dr. Michael
Milosevic, CARO President, "This fellowship program enables deserving
individuals such as Dr. Palma to conduct important research and further their
training and development in radiation oncology in a manner that will directly
benefit Canadians with cancer in the future."
Canadian Association of Radiation Oncology (CARO) - Association
canadienne de radio-oncologie (ACRO) is a not-for-profit association with a
mandate to represent and support its membership nationally and internationally
through the promotion of high standards of patient care in the practice of
radiation oncology, support of excellence in professional standards, promotion
of radiation oncology research and education.
CARO is a partner with other disciplines in seeking to improve the
outcome of cancer patients and provides a consultative authority to oncology
related agencies, academic institutions and to the public in all matters
pertaining to radiotherapy and oncology in Canada.
For more information about CARO, please visit email@example.com
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated state of the art tools and treatment planning systems
for radiation therapy and radiosurgery, as well as workflow enhancing software
systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to both
healthcare providers and patients, Elekta aims to improve, prolong and even
save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over
5,000 hospitals globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution from the Elekta
Elekta employs around 2,500 employees globally. The corporate headquarter
is located in Stockholm, Sweden, and the company is listed on the Nordic
Exchange under the ticker EKTAb. For more information about Elekta, please
For further information:
For further information: S. Murdock, CARO, Tel: (613) 260-4188,